Browsing by Author Nicolaides, C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 30  next >
TitleAuthor(s)Issue date
Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?Liberopoulos, E.; Karabina, S. A.; Tselepis, A.; Bairaktari, E.; Nicolaides, C.; Pavlidis, N.; Elisaf, M.24-Nov-2015
Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin: biological and clinical implications. A Hellenic Co-operative Oncology Group studyBriasoulis, E.; Tsokos, M.; Fountzilas, G.; Bafaloukos, D.; Kosmidis, P.; Samantas, E.; Skarlos, D.; Nicolaides, C.; Pavlidis, N.24-Nov-2015
The beneficial effect of tamoxifen on serum lipoprotein-A levels: an additional anti-atherogenic propertyElisaf, M. S.; Bairaktari, E.; Nicolaides, C.; Fountzilas, G.; Tzallas, C.; Siamopoulos, K.; Tsolas, O.; Pavlidis, N.24-Nov-2015
Clinical value of CA 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patientsPectasides, D.; Pavlidis, N.; Gogou, L.; Antoniou, F.; Nicolaides, C.; Tsikalakis, D.24-Nov-2015
Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group StudyNicolaides, C.; Fountzilas, G.; Zoumbos, N.; Skarlos, D.; Kosmidis, P.; Pectasides, D.; Karabelis, A.; Giannakakis, T.; Symeonidis, A.; Papadopoulos, A.; Antoniou, F.; Pavlidis, N.24-Nov-2015
Do LH-RH analogues induce effects similar to tamoxifen on serum lipid parameters in premenopausal women with breast cancer? A prospective studyElisaf, M. S.; Bairaktari, E.; Nicolaides, C.; Fountzilas, G.; Tzallas, C.; Tsolas, O.; Siamopoulos, K.; Pavlidis, N.24-Nov-2015
Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: a Hellenic Cooperative Oncology Group Phase II studyFountzilas, G.; Nicolaides, C.; Bafaloukos, D.; Kalogera-Fountzila, A.; Kalofonos, H.; Samelis, G.; Aravantinos, G.; Pavlidis, N.24-Nov-2015
Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility studyFountzilas, G.; Nicolaides, C.; Aravantinos, G.; Skarlos, D.; Kosmidis, P.; Papakostas, P.; Stathopoulos, G. P.; Kontostolis, E.; Bafaloukos, D.; Pavlidis, N.24-Nov-2015
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancerFountzilas, G.; Papadimitriou, C.; Aravantinos, G.; Nicolaides, C.; Stathopoulos, G.; Bafaloukos, D.; Kalofonos, H.; Ekonomopoulos, T.; Skarlos, D.; Pavlidis, N.; Dimopoulos, A. M.24-Nov-2015
Effect of letrozole on the lipid profile in postmenopausal women with breast cancerElisaf, M. S.; Bairaktari, E. T.; Nicolaides, C.; Kakaidi, B.; Tzallas, C. S.; Katsaraki, A.; Pavlidis, N. A.24-Nov-2015
The effect of the aromatase inhibitor letrozole on lipid parameters in postmenopausal women with metastatic breast cancer. A preliminary report.Nicolaides, C.; Elisaf, M. S.; Bairaktari, E.; Kakaidi, V.; Katsaraki, A.; Pavlidis, N.24-Nov-2015
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Dimopoulos, A. M.; Papadimitriou, C.; Kalogera-Fountzila, A.; Aravantinos, G.; Bafaloukos, D.; Athanassiades, A.; Nicolaides, C.; Keramopoulos, A.; Pavlidis, N.; Kosmidis, P.; Skarlos, D.24-Nov-2015
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology GroupNicolaides, C.; Dimopoulos, M. A.; Samantas, E.; Bafaloukos, D.; Kalofonos, C.; Fountzilas, G.; Razi, E.; Kosmidis, P.; Pavlidis, N.24-Nov-2015
Intensified carboplatin regimen with GM-CSF support in non-small cell lung cancer (NSCLC). A Hellenic Co-operative Oncology Group Study (HeCOG)Nicolaides, C.; Klouvas, G.; Fountzilas, G.; Athanassiadis, A.; Skarlos, D.; Samantas, E.; Kosmidis, P.; Mylonakis, N.; Pavlidis, N.24-Nov-2015
Is the combination of 5-fluorouracil and folinic acid effective in advanced gastric carcinoma? Results of a pilot study and review of the literaturePavlidis, N.; Nicolaides, C.; Klouvas, G.; Briassoulis, E.24-Nov-2015
Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomasBai, M.; Vlachonikolis, J.; Agnantis, N. J.; Tsanou, E.; Dimou, S.; Nicolaides, C.; Stefanaki, S.; Pavlidis, N.; Kanavaros, P.24-Nov-2015
Metronomic oral vinorelbine (MOVIN): a dose establishing translational and pharmacokinetic study in patients with metastatic refractory cancerBriasoulis, E.; Tolis, C.; Pappas, P.; Marselos, M.; Nicolaides, C.; Nikiforidis, L.; Nikolaidou, M.; Siarabi, O.; Tzamakou, E.; Pavlidis, N.24-Nov-2015
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Stathopoulos, G.; Nicolaides, C.; Kalogera-Fountzila, A.; Kalofonos, H.; Nikolaou, A.; Bacoyiannis, C.; Samantas, E.; Papadimitriou, C.; Kosmidis, P.; Daniilidis, J.; Pavlidis, N.24-Nov-2015
Phase II study of 5-fluorouracil and interferon-gamma in patients with metastatic colorectal cancer. A Hellenic Cooperative Oncology Group StudyPavlidis, N.; Nicolaides, C.; Athanassiadis, A.; Beriatou, K.; Skarlos, D.; Giannakakis, T.; Kosmidis, P.; Karvounis, N.; Fountzilas, G.24-Nov-2015
A phase II trial of carboplatin and vindesine in patients with non-small cell lung cancer. A Hellenic Cooperative Oncology Group studyPavlidis, N. A.; Klouvas, G.; Nicolaides, C.; Karantanas, A.; Beer, M.; Fountzilas, G.24-Nov-2015